Selecta Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$219,710,000 over the previous period. Total operating expenses were $112,420,000.

Profit Margin

Selecta Biosciences, Inc. (NASDAQ:SELB): Profit margin
2014 3.04M -12.88M -423.68%
2015 6.01M -25.17M -418.8%
2016 8.08M -36.21M -447.98%
2017 207K -65.32M -31556.04%
2018 903K -65.33M -7235.44%
2019 6.67M -53.53M -801.8%
2020 16.59M -69.78M -420.48%
2021 85.07M -25.68M -30.19%
2022 110.77M 35.37M 31.94%
2023 0 -219.71M

SELB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0110.77M85.07M16.59M6.67M903K207K8.08M6.01M3.04M
Cost of revenue
072.37M68.73M54.50M42.74M00000
Gross profit
038.4M16.34M-37.90M-36.06M903K207K8.08M6.01M3.04M
Operating exp.
Research and development
71.83M72.37M68.73M54.50M42.74M47.68M45.16M29.70M22.98M10.48M
Selling and marketing
0000000000
Total operating expenses
112.42M96.23M89.67M73.41M59.13M65.92M63.99M42.75M31.31M18.43M
Operating income
-86.41M14.53M-4.59M-56.82M-52.45M-65.02M-63.78M-34.67M-25.30M-15.39M
Other income (expenses), net
-152.29M20.23M-5.12M-12.05M-2.89M1.18M-1.53M-287K130K2.51M
Income before tax
-238.71M34.77M-9.72M-68.87M-55.35M-65.33M-65.32M-36.21M-25.17M-12.88M
Income tax expense
19M-609K15.96M911K-1.81M1.18M304K455K922K508K
Net income
-219.71M35.37M-25.68M-69.78M-53.53M-65.33M-65.32M-36.21M-25.17M-12.88M
Earnings per share
Basic EPS
-0.000.24-0.22-0.69-1.18-2.92-3.2-3.45-1.96-1
Diluted EPS
-0.000.1-0.22-0.69-1.18-2.92-3.2-3.45-1.96-1
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source